Created in 2004 and based in Montpellier, Intrasense (FR0011179886 – ALINS) has a subsidiary in China and a distribution network covering four continents.
Intrasense is a medtech company specializing in medical imaging software solutions that develops and markets software platforms in 40 countries that facilitate and secure diagnosis, decision-making and therapeutic monitoring. Intrasense is the designer of Myrian®, an advanced radiology visualization solution that provides 1,200 healthcare establishments with clinical applications to aid in the interpretation of all types of images. Since 2021, Intrasense has been developing Liflow®, a new platform dedicated to oncology, multidisciplinary and collaborative, making it possible to optimize patient care and monitoring. A subsidiary of the Guerbet group since June 2023, Intrasense continues to enrich its solutions by integrating artificial intelligence algorithms in medical imaging. Its teams work closely with healthcare professionals to help save lives. ES
Intrasense offers innovative and collaborative solutions perfectly integrated into all health information systems:
- 18 advanced clinical applications
- Regulatory compliant in 40 countries
- Installed on more than 1,200 customer sites around the world
- 170 scientific publications and several technological patents
Historical
In June 2023, lntrasense and Guerbet, a global specialist in contrast products and solutions for medical imaging, signed a non-exclusive licensing agreement to integrate and market Guerbet's artificial intelligence algorithms within lntrasense software platforms. Since then, Intransense has been a subsidiary of the Guerbet Group.
The company has 60 employees.